Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:1101-1111

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steinberg, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steinberg, S. F.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Heart failure - basic studies
(Circulation Research. 1999;85:1101.)
© 1999 American Heart Association, Inc.


MiniReviews

The Molecular Basis for Distinct ß-Adrenergic Receptor Subtype Actions in Cardiomyocytes

Susan F. Steinberg

From the Departments of Pharmacology and Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.

Correspondence to Susan F. Steinberg, MD, Associate Professor of Pharmacology and Medicine, Department of Pharmacology, College of Physicians and Surgeons, Columbia University, 630 West 168th St, New York, NY 10032. E-mail sfs1@columbia.edu


Key Words: ß-adrenergic receptor subtype • cardiomyocyte • cAMP • contractility


*    Introduction
 
Catecholamines exert physiologically important effects on the electrical properties and mechanical performance of the heart through the activation of adrenergic receptors. It has been 50 years since Ahlquist1 first postulated that the excitatory and inhibitory pressor responses to catecholamines must be mediated by distinct adrenergic receptors (ARs), then designated {alpha} (for excitatory) and ß (for inhibitory). Ahlquist’s classification was expanded further by Lands et al,2 who recognized that both {alpha}- and ß-ARs could be conveniently categorized into 2 distinct subtypes on the basis of their relative potencies for ligands available at that time. In the ensuing years, the predominant AR expressed by cardiomyocytes was shown to conform to the ß1-AR subtype. Our understanding of the molecular basis for sympathetic modulation was advanced further by the observations that under normal physiological conditions catecholamines induce positive inotropic, chronotropic, and lusitropic (relaxant) responses in the heart through a ß1-AR–activated pathway, which involves the stimulatory GTP regulatory protein (Gs), activation of adenylyl cyclase (AC), accumulation of cAMP, stimulation of cAMP-dependent protein kinase A (PKA), and phosphorylation of key target proteins (including the L-type calcium channel [ICa,L], phospholamban [PLB], and troponin I [TNI]). Potential contributions of other AR subtypes to the mechanism(s) of catecholamine action in the heart were largely ignored in early studies. However, the traditional notion that only ß1-ARs support cardiac contractile function has been challenged by recent research demonstrating that cardiac myocytes also express ß2-ARs that link to important changes in cardiac contractile function. Although these . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
EuropaceHome page
R. J. Selvaraj, A. M. Suszko, A. Subramanian, K. Nanthakumar, and V. S. Chauhan
Adrenergic stimulation increases repolarization dispersion and reduces activation-repolarization coupling along the RV endocardium of patients with cardiomyopathy
Europace, November 1, 2009; 11(11): 1529 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. E. Vinge, P. W. Raake, and W. J. Koch
Gene Therapy in Heart Failure
Circ. Res., June 20, 2008; 102(12): 1458 - 1470.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. DeSantiago, X. Ai, M. Islam, G. Acuna, M. T. Ziolo, D. M. Bers, and S. M. Pogwizd
Arrhythmogenic Effects of {beta}2-Adrenergic Stimulation in the Failing Heart Are Attributable to Enhanced Sarcoplasmic Reticulum Ca Load
Circ. Res., June 6, 2008; 102(11): 1389 - 1397.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. G. Khasar, J. Burkham, O. A. Dina, A. S. Brown, O. Bogen, N. Alessandri-Haber, P. G. Green, D. B. Reichling, and J. D. Levine
Stress Induces a Switch of Intracellular Signaling in Sensory Neurons in a Model of Generalized Pain
J. Neurosci., May 28, 2008; 28(22): 5721 - 5730.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sabri, K. Rafiq, R. Seqqat, M. A. Kolpakov, R. Dillon, and L. J. Dell'italia
Sympathetic Activation Causes Focal Adhesion Signaling Alteration in Early Compensated Volume Overload Attributable to Isolated Mitral Regurgitation in the Dog
Circ. Res., May 9, 2008; 102(9): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. K. Means, S. Miyamoto, J. Chun, and J. H. Brown
S1P1 Receptor Localization Confers Selectivity for Gi-mediated cAMP and Contractile Responses
J. Biol. Chem., May 2, 2008; 283(18): 11954 - 11963.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. A. Faucher, F. E. Gannier, J. M. Lignon, P. Cosnay, and C. O. Malecot
Roles of PKA, PI3K, and cPLA2 in the NO-mediated negative inotropic effect of {beta}2-adrenoceptor agonists in guinea pig right papillary muscles
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C106 - C117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. McConville, E. G. Lakatta, and R. G. Spencer
Greater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heart
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1828 - E1835.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. E. Hebert
Anti-{beta}1AR antibodies in dilated cardiomyopathy: Are these a new class of receptor agonists?
Cardiovasc Res, October 1, 2007; 76(1): 5 - 7.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Boivin, C. Lavoie, G. Vaniotis, A. Baragli, L.-R. Villeneuve, N. Ethier, P. Trieu, B. G. Allen, and T. E. Hebert
Functional {beta}-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes
Cardiovasc Res, July 1, 2006; 71(1): 69 - 78.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Germack and J. M. Dickenson
Induction of {beta}3-Adrenergic Receptor Functional Expression following Chronic Stimulation with Noradrenaline in Neonatal Rat Cardiomyocytes
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 392 - 402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. B. Patrick, J. McHowat, T. A. Rosenberger, S. I. Rapoport, and E. J. Murphy
Arachidonic acid incorporation and turnover is decreased in sympathetically denervated rat heart
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2611 - H2619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ait-Mamar, M. Cailleret, C. Rucker-Martin, A. Bouabdallah, G. Candiani, C. Adamy, P. Duvaldestin, F. Pecker, N. Defer, and C. Pavoine
The Cytosolic Phospholipase A2 Pathway, a Safeguard of {beta}2-Adrenergic Cardiac Effects in Rat
J. Biol. Chem., May 13, 2005; 280(19): 18881 - 18890.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Cheng, F. Qiao, T. N. Gallien, D. Kuppuswamy, and G. Cooper IV
Inhibition of {beta}-adrenergic receptor trafficking in adult cardiocytes by MAP4 decoration of microtubules
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1193 - H1202.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Kies, T. Wichter, M. Schafers, M. Paul, K. P. Schafers, L. Eckardt, L. Stegger, E. Schulze-Bahr, O. Rimoldi, G. Breithardt, et al.
Abnormal Myocardial Presynaptic Norepinephrine Recycling in Patients With Brugada Syndrome
Circulation, November 9, 2004; 110(19): 3017 - 3022.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Wang, W. Zhu, S. Wang, D. Yang, M. T. Crow, R.-P. Xiao, and H. Cheng
Sustained {beta}1-Adrenergic Stimulation Modulates Cardiac Contractility by Ca2+/Calmodulin Kinase Signaling Pathway
Circ. Res., October 15, 2004; 95(8): 798 - 806.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. J. Murphy, G. Barcelo-Coblijn, B. Binas, and J. F. C. Glatz
Heart Fatty Acid Uptake Is Decreased in Heart Fatty Acid-binding Protein Gene-ablated Mice
J. Biol. Chem., August 13, 2004; 279(33): 34481 - 34488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. W. Rodenbaugh, H. L. Collins, D. G. Nowacek, and S. E. DiCarlo
Increased susceptibility to ventricular arrhythmias is associated with changes in Ca2+ regulatory proteins in paraplegic rats
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2605 - H2613.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Foerster, F. Groner, J. Matthes, W. J. Koch, L. Birnbaumer, and S. Herzig
Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through {beta}2-adrenoceptors
PNAS, November 25, 2003; 100(24): 14475 - 14480.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Lohse, S. Engelhardt, and T. Eschenhagen
What Is the Role of {beta}-Adrenergic Signaling in Heart Failure?
Circ. Res., November 14, 2003; 93(10): 896 - 906.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Pavoine, N. Behforouz, C. Gauthier, S. Le Gouvello, F. Roudot-Thoraval, C. R. Martin, A. Pawlak, C. Feral, N. Defer, R. Houel, et al.
{beta}2-Adrenergic Signaling in Human Heart: Shift from the Cyclic AMP to the Arachidonic Acid Pathway
Mol. Pharmacol., November 1, 2003; 64(5): 1117 - 1125.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Jurevicius, V A. Skeberdis, and R. Fischmeister
Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following {beta}2-adrenergic stimulation of ICa,L in frog ventricular myocytes
J. Physiol., August 15, 2003; 551(1): 239 - 252.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. GEORGET, P. MATEO, G. VANDECASTEELE, L. LIPSKAIA, N. DEFER, J. HANOUNE, J. HOERTER, C. LUGNIER, and R. FISCHMEISTER
Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8)
FASEB J, August 1, 2003; 17(11): 1380 - 1391.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Hu, W. Chen, N. P. Martin, E. J. Whalen, R. T. Premont, and R. J. Lefkowitz
GIPC Interacts with the {beta}1-Adrenergic Receptor and Regulates {beta}1-Adrenergic Receptor-mediated ERK Activation
J. Biol. Chem., July 3, 2003; 278(28): 26295 - 26301.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. O. Rybin, E. Pak, S. Alcott, and S. F. Steinberg
Developmental Changes in {beta}2-Adrenergic Receptor Signaling in Ventricular Myocytes: the Role of Gi proteins and Caveolae Microdomains
Mol. Pharmacol., June 1, 2003; 63(6): 1338 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Bartel, E.-G. Krause, G. Wallukat, and P. Karczewski
New insights into {beta}2-adrenoceptor signaling in the adult rat heart
Cardiovasc Res, March 1, 2003; 57(3): 694 - 703.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Leineweber, K. Brandt, B. Wludyka, A. Beilfuss, K. Ponicke, I. Heinroth-Hoffmann, and O.-E. Brodde
Ventricular Hypertrophy Plus Neurohumoral Activation Is Necessary to Alter the Cardiac {beta}-Adrenoceptor System in Experimental Heart Failure
Circ. Res., November 29, 2002; 91(11): 1056 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Mieno, H. Horimoto, F. Watanabe, Y. Nakai, E. Furuya, and S. Sasaki
Potent adenylate cyclase agonist forskolin restores myoprotective effects of ischemic preconditioning in rat hearts after myocardial infarction
Ann. Thorac. Surg., October 1, 2002; 74(4): 1213 - 1218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xiang, V. O. Rybin, S. F. Steinberg, and B. Kobilka
Caveolar Localization Dictates Physiologic Signaling of beta 2-Adrenoceptors in Neonatal Cardiac Myocytes
J. Biol. Chem., September 6, 2002; 277(37): 34280 - 34286.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. N Dedkova, Y. Gao Wang, L. A Blatter, and S. L Lipsius
Nitric oxide signalling by selective {beta}2-adrenoceptor stimulation prevents ACh-induced inhibition of {beta}2-stimulated Ca2+ current in cat atrial myocytes
J. Physiol., August 1, 2002; 542(3): 711 - 723.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Feldman
Adenylyl Cyclase: A New Target for Heart Failure Therapeutics
Circulation, April 23, 2002; 105(16): 1876 - 1878.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse
Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice
Circ. Res., April 19, 2002; 90(7): 814 - 819.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Pi, K. R. Kemnitz, D. Zhang, E. G. Kranias, and J. W. Walker
Phosphorylation of Troponin I Controls Cardiac Twitch Dynamics: Evidence From Phosphorylation Site Mutants Expressed on a Troponin I-Null Background in Mice
Circ. Res., April 5, 2002; 90(6): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Ponicke, I. Heinroth-Hoffmann, and O.-E. Brodde
Differential Effects of Bucindolol and Carvedilol on Noradenaline-Induced Hypertrophic Response in Ventricular Cardiomyocytes of Adult Rats
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 71 - 76.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Hakuno, K. Fukuda, S. Makino, F. Konishi, Y. Tomita, T. Manabe, Y. Suzuki, A. Umezawa, and S. Ogawa
Bone Marrow-Derived Regenerated Cardiomyocytes (CMG Cells) Express Functional Adrenergic and Muscarinic Receptors
Circulation, January 22, 2002; 105(3): 380 - 386.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn
Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action
Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
Y. G. Wang, E. N. Dedkova, S. F. Steinberg, L. A. Blatter, and S. L. Lipsius
{beta}2-Adrenergic Receptor Signaling Acts via No Release to Mediate Ach-Induced Activation of Atp-Sensitive K+ Current in Cat Atrial Myocytes
J. Gen. Physiol., January 1, 2002; 119(1): 69 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Ostrom, C. Gregorian, R. M. Drenan, Y. Xiang, J. W. Regan, and P. A. Insel
Receptor Number and Caveolar Co-localization Determine Receptor Coupling Efficiency to Adenylyl Cyclase
J. Biol. Chem., November 2, 2001; 276(45): 42063 - 42069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Magne, D. Couchie, F. Pecker, and C. Pavoine
beta 2-Adrenergic Receptor Agonists Increase Intracellular Free Ca2+ Concentration Cycling in Ventricular Cardiomyocytes through p38 and p42/44 MAPK-mediated Cytosolic Phospholipase A2 Activation
J. Biol. Chem., October 19, 2001; 276(43): 39539 - 39548.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Devic, Y. Xiang, D. Gould, and B. Kobilka
beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice
Mol. Pharmacol., September 1, 2001; 60(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. F. Steinberg
G protein-coupled receptor kinases: gotta real kure for heart failure?
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 541 - 545.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-S. Zhang, H.-J. Cheng, T. Ukai, H. Tachibana, and C.-P. Cheng
Enhanced Cardiac L-Type Calcium Current Response to beta 2-Adrenergic Stimulation in Heart Failure
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 188 - 196.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Moniotte, L. Kobzik, O. Feron, J.-N. Trochu, C. Gauthier, and J.-L. Balligand
Upregulation of {beta}3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium
Circulation, March 27, 2001; 103(12): 1649 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. McHowat, P. S. Tappia, S.-Y. Liu, R. McCrory, and V. Panagia
Redistribution and abnormal activity of phospholipase A2 isoenzymes in postinfarct congestive heart failure
Am J Physiol Cell Physiol, March 1, 2001; 280(3): C573 - C580.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Zhong, J. R Hume, and K. D Keef
{beta}-Adrenergic receptor stimulation of L-type Ca2+ channels in rabbit portal vein myocytes involves both {alpha}s and {beta}{gamma} G protein subunits
J. Physiol., February 15, 2001; 531(1): 105 - 115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Jain, C. C. Lim, K. Nagata, V. M. Davis, D. S. Milstone, R. Liao, and R. M. Mortensen
Targeted inactivation of G{alpha}i does not alter cardiac function or {beta}-adrenergic sensitivity
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H569 - H575.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. F. Steinberg
The Cellular Actions of {beta}-Adrenergic Receptor Agonists : Looking Beyond cAMP
Circ. Res., December 8, 2000; 87(12): 1079 - 1082.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. J. Kamp and J. W. Hell
Regulation of Cardiac L-Type Calcium Channels by Protein Kinase A and Protein Kinase C
Circ. Res., December 8, 2000; 87(12): 1095 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. D. Kilts, M. A. Gerhardt, M. D. Richardson, G. Sreeram, G. B. Mackensen, H. P. Grocott, W. D. White, R. D. Davis, M. F. Newman, J. G. Reves, et al.
{beta}2-Adrenergic and Several Other G Protein-Coupled Receptors in Human Atrial Membranes Activate Both Gs and Gi
Circ. Res., October 13, 2000; 87(8): 705 - 709.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Molenaar, S. Bartel, A. Cochrane, D. Vetter, H. Jalali, P. Pohlner, K. Burrell, P. Karczewski, E.-G. Krause, and A. Kaumann
Both {beta}2- and {beta}1-Adrenergic Receptors Mediate Hastened Relaxation and Phosphorylation of Phospholamban and Troponin I in Ventricular Myocardium of Fallot Infants, Consistent With Selective Coupling of {beta}2-Adrenergic Receptors to Gs-Protein
Circulation, October 10, 2000; 102(15): 1814 - 1821.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. G. Wang, A. M Samarel, and S. L Lipsius
Laminin binding to {beta}1-integrins selectively alters {beta}1- and {beta}2-adrenoceptor signalling in cat atrial myocytes
J. Physiol., August 15, 2000; 527(1): 3 - 9.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sabri, E. Pak, S. A. Alcott, B. A. Wilson, and S. F. Steinberg
Coupling Function of Endogenous {alpha}1- and {beta}-Adrenergic Receptors in Mouse Cardiomyocytes
Circ. Res., May 26, 2000; 86(10): 1047 - 1053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. O. Rybin, X. Xu, M. P. Lisanti, and S. F. Steinberg
Differential Targeting of beta -Adrenergic Receptor Subtypes and Adenylyl Cyclase to Cardiomyocyte Caveolae. A MECHANISM TO FUNCTIONALLY REGULATE THE cAMP SIGNALING PATHWAY
J. Biol. Chem., December 22, 2000; 275(52): 41447 - 41457.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-C. Wellner-Kienitz, K. Bender, and L. Pott
Overexpression of beta 1 and beta 2 Adrenergic Receptors in Rat Atrial Myocytes. DIFFERENTIAL COUPLING TO G PROTEIN-GATED INWARD RECTIFIER K+ CHANNELS VIA Gs AND Gi/o
J. Biol. Chem., September 28, 2001; 276(40): 37347 - 37354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xu, M. Paquet, A. G. Lau, J. D. Wood, C. A. Ross, and R. A. Hall
beta 1-Adrenergic Receptor Association with the Synaptic Scaffolding Protein Membrane-associated Guanylate Kinase Inverted-2 (MAGI-2). DIFFERENTIAL REGULATION OF RECEPTOR INTERNALIZATION BY MAGI-2 AND PSD-95
J. Biol. Chem., October 26, 2001; 276(44): 41310 - 41317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. F. Steinberg, S. Alcott, E. Pak, D. Hu, L. Protas, N. S. Moise, R. B. Robinson, and M. R. Rosen
beta 1-Receptors increase cAMP and induce abnormal Cai cycling in the German shepherd sudden death model
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1181 - H1188.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Pi, K. R. Kemnitz, D. Zhang, E. G. Kranias, and J. W. Walker
Phosphorylation of Troponin I Controls Cardiac Twitch Dynamics: Evidence From Phosphorylation Site Mutants Expressed on a Troponin I-Null Background in Mice
Circ. Res., April 5, 2002; 90(6): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse
Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice
Circ. Res., April 19, 2002; 90(7): 814 - 819.
[Abstract] [Full Text] [PDF]